$30.00
At close: May 23, 3:44 PM EDT
Comments
Loading...
ResMed Analyst Ratings and Price Targets | OTC:RSMDF | Benzinga
ResMed Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for ResMed Corp from these most-recent analyst ratings.
Analyst Ratings for ResMed
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for ResMed (RSMDF) stock?
There is no price target for ResMed
What is the most recent analyst rating for ResMed (RSMDF)?
There is no analyst for ResMed
When was the last upgrade for ResMed (RSMDF)?
There is no last upgrade for ResMed
When was the last downgrade for ResMed (RSMDF)?
There is no last downgrade for ResMed.
When is the next analyst rating going to be posted or updated for ResMed (RSMDF)?
There is no next analyst rating for ResMed.
Is the Analyst Rating ResMed (RSMDF) correct?
There is no next analyst rating for ResMed.
Browse analyst ratings and price targets on all stocks.
